Cargando…
Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant phenotype of glioblastoma multiforme (GBM), the most aggressive primary brain tumor. We initially looked for unbalanced genomic rearrangements in the Sox2 locus in 42 GBM samples and found that Sox2...
Autores principales: | Alonso, Marta M., Diez-Valle, Ricardo, Manterola, Lorea, Rubio, Angel, Liu, Dan, Cortes-Santiago, Nahir, Urquiza, Leire, Jauregi, Patricia, de Munain, Adolfo Lopez, Sampron, Nicolás, Aramburu, Ander, Tejada-Solís, Sonia, Vicente, Carmen, Odero, María D., Bandrés, Eva, García-Foncillas, Jesús, Idoate, Miguel A., Lang, Frederick F., Fueyo, Juan, Gomez-Manzano, Candelaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206066/ https://www.ncbi.nlm.nih.gov/pubmed/22069467 http://dx.doi.org/10.1371/journal.pone.0026740 |
Ejemplares similares
-
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
por: Garros-Regulez, Laura, et al.
Publicado: (2016) -
miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs
por: de la Rocha, Arlet María Acanda, et al.
Publicado: (2020) -
Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3
and RAB31 and promotes the survival of GSCs
por: de la Rocha, Arlet María Acanda, et al.
Publicado: (2021) -
Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017) -
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)